[Recommendations for the use of palivizumab in the prevention of respiratory syncytial virus infection in late preterm infants (32(1) to 35(0) weeks of gestation)]. [electronic resource]
Producer: 20101116Description: 98.e1-4 p. digitalISSN:- 1695-9531
No physical items for this record
Publication Type: English Abstract; Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.